Correlation Between Apex Biotechnology and Sunmax Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apex Biotechnology and Sunmax Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apex Biotechnology and Sunmax Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apex Biotechnology Corp and Sunmax Biotechnology Co, you can compare the effects of market volatilities on Apex Biotechnology and Sunmax Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apex Biotechnology with a short position of Sunmax Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apex Biotechnology and Sunmax Biotechnology.

Diversification Opportunities for Apex Biotechnology and Sunmax Biotechnology

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Apex and Sunmax is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Apex Biotechnology Corp and Sunmax Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunmax Biotechnology and Apex Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apex Biotechnology Corp are associated (or correlated) with Sunmax Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunmax Biotechnology has no effect on the direction of Apex Biotechnology i.e., Apex Biotechnology and Sunmax Biotechnology go up and down completely randomly.

Pair Corralation between Apex Biotechnology and Sunmax Biotechnology

Assuming the 90 days trading horizon Apex Biotechnology Corp is expected to generate 1.27 times more return on investment than Sunmax Biotechnology. However, Apex Biotechnology is 1.27 times more volatile than Sunmax Biotechnology Co. It trades about 0.27 of its potential returns per unit of risk. Sunmax Biotechnology Co is currently generating about -0.08 per unit of risk. If you would invest  2,795  in Apex Biotechnology Corp on October 11, 2024 and sell it today you would earn a total of  210.00  from holding Apex Biotechnology Corp or generate 7.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Apex Biotechnology Corp  vs.  Sunmax Biotechnology Co

 Performance 
       Timeline  
Apex Biotechnology Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Apex Biotechnology Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Apex Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Sunmax Biotechnology 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sunmax Biotechnology Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Sunmax Biotechnology may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Apex Biotechnology and Sunmax Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apex Biotechnology and Sunmax Biotechnology

The main advantage of trading using opposite Apex Biotechnology and Sunmax Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apex Biotechnology position performs unexpectedly, Sunmax Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunmax Biotechnology will offset losses from the drop in Sunmax Biotechnology's long position.
The idea behind Apex Biotechnology Corp and Sunmax Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities